CMB 0.00% 0.4¢ cambium bio limited

REGENEUS undervalued on comparison BIOSHARES BUY REC, page-9

  1. 13 Posts.
    The Progenza preclinical results are important I think. The human safety trial is highly likely to go well. There have been so many MSC trials and they are safe. Unlikely RGS will have a problem here.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.